Video
6 Oct 2020

BioVectra's CDMO Capabilities

Watch Video

BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients (APIs) from five North American cGMP facilities. We specialize in Microbial Fermentation, Complex Chemistry, Biologics, and Formulation Development.

Read more Show less
Content provided by our supplier

BioVectra Inc.

  • CA
  • 2015
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Primary activities
Biopharmaceutical
View company profile

Other Content from BioVectra Inc. (1)

  • BioVectra Inc. announces a $144.6 million expansion project

    News BioVectra Inc. announces a $144.6 million expansion project

    BioVectra Inc., an Atlantic Canadian Contract Development and Manufacturing Organization (CDMO), announces a five-year, $144.6 million (CAD) expansion project to enhance its Biopharmaceutical capabilities in both Charlottetown, Prince Edward Island and Windsor, Nova Scotia.
    2 Sep 2019